Anxiety in young children: A randomised controlled trial of a new cognitive-behaviourally based parenting intervention

ISRCTN ISRCTN12166762
DOI https://doi.org/10.1186/ISRCTN12166762
Secondary identifying numbers G108/604
Submission date
12/04/2005
Registration date
30/06/2005
Last edited
23/02/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Sam Cartwright-Hatton
Scientific

School of Psychological Sciences
Zochonis Building
Brunswick St
Manchester
M13 9PL
United Kingdom

Phone +44 (0)161 275 2576
Email sam.cartwright-hatton@manchester.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Taking part information is found in http://www.psych-sci.manchester.ac.uk/pacmantrial/takingpart/
Scientific title
Study acronymPACMAN trial (Parenting for Anxious Children - Manchester)
Study objectivesParticipants randomised to receive a new cognitive-behaviourally based parenting intervention will exhibit greater reductions in anxiety disorders and internalising symptoms than:
a. Those who have been in a waiting list control group, after the end of the intervention period (10 weeks)
b. Those who were on the waiting list, and subsequently received ‘treatment as usual’ at 12 months follow-up
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedAnxiety Disorders
InterventionExperimental intervention: 10 week course of 2-h group sessions for parents. Content is cognitive-behaviourally based parenting advice, focussing on gentle and consistent discipline, relationship building, and techniques to manage worry and fear.

Control intervention: 10 weeks wait list, followed by treatment as usual.
Intervention typeOther
Primary outcome measureThe primary outcome point is after 10 weeks participation in the trial, comparing those who have received the new intervention, and those who have remained on a waiting list. The primary outcome measure will be parent report of ‘internalising symptoms’ on the ‘Child Behavior Checklist’.
Secondary outcome measuresThe secondary outcome point is after 12 months in the trial where those who received the new intervention, and those who remained on a waiting list for at least 10 weeks before receiving ‘treatment as usual’ will be compared. The secondary outcome measures are teacher report of ‘internalising symptoms’ on the ‘Child Behavior Checklist – teacher report form’; and DSM-IV Anxiety Disorder diagnosis.
Overall study start date31/03/2005
Completion date30/06/2008

Eligibility

Participant type(s)Patient
Age groupChild
Upper age limit10 Years
SexBoth
Target number of participants72. Added 07/09/09: referrals are no longer accepted.
Key inclusion criteriaFamilies of anxious children aged under 10 years. Patients will be included in the trial if they score at or above the suggested clinical cut-off for an internalising disorder on the child behaviour checklist (the primary outcome measure). However, to ensure that all participants are of clinical severity, they must also have a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of an anxiety disorder, assessed by the Anxiety Disorders Interview Schedule for Children (not including specific phobia, obsessive compulsive disorder, post-traumatic stress disorder/acute stress disorder, anxiety due to a general medical condition, or substance induced anxiety disorder). Participants will not be excluded on the grounds of other comorbid conditions.
Key exclusion criteriaParents or children with moderate to severe learning disabilities will not be included in the study. Children whose parents do not have adequate English to benefit from the group format of the intervention will not be included.
Date of first enrolment31/03/2005
Date of final enrolment30/06/2008

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

School of Psychological Sciences
Manchester
M13 9PL
United Kingdom

Sponsor information

University of Manchester (UK)
University/education

Oxford Road
Manchester
M13 9PL
England
United Kingdom

Email Anne-Marie.Brennan@manchester.ac.uk
ROR logo "ROR" https://ror.org/027m9bs27

Funders

Funder type

Research council

Medical Research Council (MRC) (UK) G108/604

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2011 Yes No